Qentoros
Blacksburg, US · Founded 2022 · Virginia corporation
Qentoros develops biologic therapeutics for veterinary medicine, with a flagship product, BIO-PLY™, a platelet-derived peptide treatment for septic arthritis and other joint and soft-tissue conditions in horses. Its products are aimed at veterinarians and equine referral centers, and the company is building a pipeline of biologics for equine conditions.
Founders & leadership
MM
MICHAEL MILLERNamed on SEC filing
JG
Jessica GilbertieNamed on SEC filing
JG
JESSICA GILBERTIENamed on SEC filing
JS
JOHN SCHOTTNamed on SEC filing
MA
MICHAEL ABBOTTNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$605K disclosed across 2 rounds · 2025–2026
▶$100KraisedAug 2026 · 2 investors · OtherRule 506(b)
▶$100KraisedAug 2026 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- JESSICA GILBERTIEExecutive Officer, Director
- MICHAEL MILLERDirector
- JOHN SCHOTTDirector
- MICHAEL ABBOTTDirector
- Offering amount
- $2M
- Amount sold
- $100K
- Minimum investment
- $25K
- First sale
- Dec 2025
- Incorporated
- Corporation, Virginia, 2022
- Federal exemptions
- 06b
▶$505KraisedAug 2026 · 9 investors · OtherRule 506(b)
▶$505KraisedAug 2026 · 9 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- JESSICA GILBERTIEExecutive Officer, Director
- MICHAEL MILLERDirector
- JOHN SCHOTTDirector
- MICHAEL ABBOTTDirector
- Offering amount
- $1.3M
- Amount sold
- $505K
- First sale
- Apr 2026
- Incorporated
- Corporation, Virginia, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Qentoros do?
- Qentoros develops biologic therapeutics for veterinary medicine, with a flagship product, BIO-PLY™, a platelet-derived peptide treatment for septic arthritis and other joint and soft-tissue conditions in horses. Its products are aimed at veterinarians and equine referral centers, and the company is building a pipeline of biologics for equine conditions.
- How much funding has Qentoros raised?
- Qentoros has disclosed $605K raised across 2 rounds.
- Where is Qentoros headquartered?
- Qentoros is headquartered in Blacksburg, US.